Show simple item record

dc.contributor.authorRamirez, Peter W
dc.contributor.authorDePaula-Silva, Ana B
dc.contributor.authorSzaniawski, Matt
dc.contributor.authorBarker, Edward
dc.contributor.authorBosque, Alberto
dc.contributor.authorPlanelles, Vicente
dc.date.accessioned2015-09-01T17:40:18Z
dc.date.available2015-09-01T17:40:18Z
dc.date.issued2015-07-28
dc.identifier.citationRetrovirology. 2015 Jul 28;12(1):65
dc.identifier.urihttp://dx.doi.org/10.1186/s12977-015-0192-2
dc.identifier.urihttp://hdl.handle.net/10724/31849
dc.description.abstractAbstract Background Hijacking of the cullin-RING E3 ubiquitin ligase (CRL) machinery is a common mechanism employed by diverse groups of viruses for the efficient counteraction and degradation of host proteins. In particular, HIV-1 Vpu usurps the SCFβ-TrCP E3 ubiquitin ligase complex to mark CD4 for degradation by the 26S proteasome. Vpu also interacts with and downmodulates a number of other host proteins, including the restriction factor BST-2. However, whether Vpu primarily relies on a cullin-dependent or -independent mechanism to antagonize its cellular targets has not been fully elucidated. Results We utilized a sulphamate AMP analog, MLN4924, to effectively block the activation of CRLs within infected primary CD4+ T cells. MLN4924 treatment, in a dose dependent manner, efficiently relieved surface downmodulation and degradation of CD4 by NL4-3 Vpu. MLN4924 inhibition was highly specific, as this inhibitor had no effect on Nef’s ability to downregulate CD4, which is accomplished by a CRL-independent mechanism. In contrast, NL4-3 Vpu’s capacity to downregulate BST-2, NTB-A and CCR7 was not inhibited by the drug. Vpu’s from both a transmitted founder (T/F) and chronic carrier (CC) virus preserved the ability to downregulate BST-2 in the presence of MLN4924. Finally, depletion of cellular pools of cullin 1 attenuated Vpu’s ability to decrease CD4 but not BST-2 surface levels. Conclusions We conclude that Vpu employs both CRL-dependent and CRL-independent modes of action against host proteins. Notably, we also establish that Vpu-mediated reduction of BST-2 from the cell surface is independent of β-TrCP and the CRL- machinery and this function is conserved by Vpu’s from primary isolates. Therefore, potential therapies aimed at antagonizing the activities of Vpu may need to address these distinct mechanisms of action in order to achieve a maximal effect.
dc.titleHIV-1 Vpu utilizes both cullin-RING ligase (CRL) dependent and independent mechanisms to downmodulate host proteins
dc.typeJournal Article
dc.date.updated2015-07-29T18:43:09Z
dc.language.rfc3066en
dc.rights.holderRamirez et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record